We first elucidated the expression characteristics of these regulators in a pan-cancer context (Figure 1B): (i) Expression changes of some clusters (YTHDF family, IGF2BP family, METTL14, FTO, and ALKBH5) were consistent in selected cancers. The gene discussed is ALKBH5; the disease is cancer.